"Can tranexamic acid reduce the duration of a nosebleed?"
18 to 100 years old
This study will be evaluating the benefits of topical intranasal tranexamic acid (promotes blood clotting) for patients with epistaxis (nosebleeds). Tranexamic acid is not currently approved by the FDA for the treatment of nosebleeds
This study requires
Treatment for nosebleed in ER Treatment with Tranexamic acid and direct pressure or placebo and direct pressure Follow up phone call
Who can participate?
- Diagnosed with anterior epistaxis
- Unable to consent, do not have a valid telephone number, pregnant women, prisoners, cognitively impaired individuals, diagnosis of posterior epistaxis, major trauma, bleeding disorder (such as thrombocytopenia or hemophilia), hemodynamically unstable, or had a known hypersensitivity to study medication